Clinical Trial Update: Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing Xience/Promus to Cypher for reducing late loss after stenting in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher (sirolimus-eluting coronary stent)
• Xience/Promus (not specified)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED